...
首页> 外文期刊>British Journal of Medicine and Medical Research >Effect of Raphia hookeri Seed Extract on Blood Glucose, Glycosylated Haemoglobin and Lipid Profile of Alloxan Induced Diabetic Rats
【24h】

Effect of Raphia hookeri Seed Extract on Blood Glucose, Glycosylated Haemoglobin and Lipid Profile of Alloxan Induced Diabetic Rats

机译:phi种子提取物对四氧嘧啶致糖尿病大鼠血糖,糖基化血红蛋白和脂质谱的影响

获取原文
           

摘要

Aim: To examine the effect of Raphia hookeri (RH) seed extract on blood glucose, glycosylated haemoglobin and lipid profile of alloxan induced diabetic rats. Materials and Methods: In the oral glucose tolerance test (OGTT), the animals received the extract (1 g/kg) or glibenclamide (0.01 mg/kg) or vehicle and 30 min later they received oral glucose load (1 g/kg). Glucose was estimated at 30min, 1, 2, 3 and 4 h. In hypoglycaemic study, the extract was administered at doses of 100, 250 and 500 mg/kg body weight (bwt) doses. In fasting blood glucose study (FBG), diabetic Wister rats, 5 per group, received graded doses (50, 100 and 200 mg/kg) of the extract or glibenclamide (10 mg/kg) or vehicle for 15 days. Blood was collected on days 0, 3, 5, 7, 9, 11, 13, 15 for glucose estimation. Lipid profile was analyzed using modified enzymatic procedure. Insulin assay was done by Diagnostic Automation Kit and HbA1C by standard protocol. The studies lasted for three weeks. Results: The diabetic animals treated with the extract showed appreciable weight gain. In oral glucose tolerance test (OGTT), RH seed extract and glibenclamide treated rats blood glucose significantly (P<0.05) decreased in the peak values and the area under curve after 4 h of oral load with decreased values of 48.3±1.0 mg/dL (63.3%) and 62.0±0.8 mg/dL (51.6%) respectively. The hypoglycaemic activity at 250 and 500 mg/kg body weight (bwt) doses showed lowest plasma glycaemic decrease of 50.1% and 54.4% respectively after 8 h of oral administration. In FBG study, after 15 days of extract/glibenclamide treatment, the animals’ blood glucose exacerbated by alloxan challenge returned to normal glycaemia with glycaemic decrease of 87.2±2.3 (79.3%); 57.0±1.7 (86.3%) and 55.0±0.3 mg/dL (87.1%) respectively while glibenclamide showed a maximum glycaemic decrease of 167.4±1.1 mg/dL (60.1%). The tissue morphology of the extract treated showed significant beta cells survivor. The extract ameliorated dislipidaemia and exerted significant (p<0.05) decrease in plasma HbA1C while marked increase in plasma insulin level occurred. Conclusion: The extract effectively attenuated hyperglycaemia, caused marked decrease in HbAIC concentration and ameliorated dislipidaemia.
机译:目的:研究Ra(Raphia hookeri,RH)种子提取物对四氧嘧啶致糖尿病大鼠血糖,糖基化血红蛋白和脂质分布的影响。材料和方法:在口服葡萄糖耐量试验(OGTT)中,动物接受提取物(1 g / kg)或格列本脲(0.01 mg / kg)或赋形剂,并在30分钟后接受口服葡萄糖负荷(1 g / kg) 。估计在30分钟,1、2、3和4小时时有葡萄糖。在降血糖研究中,提取物的剂量为100、250和500 mg / kg体重(bwt)剂量。在空腹血糖研究(FBG)中,糖尿病Wister大鼠(每组5只)接受分级剂量(50、100和200 mg / kg)的提取物或格列本脲(10 mg / kg)或赋形剂治疗15天。在第0、3、5、7、9、11、13、15天收集血液用于葡萄糖估计。使用改良的酶促程序分析脂质谱。通过诊断自动化试剂盒和HbA1C按照标准方案进行胰岛素测定。研究持续了三个星期。结果:用提取物处理的糖尿病动物显示出明显的体重增加。口服葡萄糖耐量试验(OGTT)中,RH种子提取物和格列本脲处理的大鼠血糖在口服4小时后的峰值和曲线下面积显着降低(P <0.05),降低值48.3±1.0 mg / dL (63.3%)和62.0±0.8 mg / dL(51.6%)。口服8小时后,在250和500 mg / kg体重(bwt)剂量下的降血糖活性显示最低的血浆血糖降低分别为50.1%和54.4%。在FBG研究中,提取物/格列本脲治疗15天后,四氧嘧啶攻击使动物血糖升高,恢复正常血糖,血糖下降87.2±2.3(79.3%)。分别为57.0±1.7(86.3%)和55.0±0.3 mg / dL(87.1%),而格列本脲显示最大降糖效果为167.4±1.1 mg / dL(60.1%)。处理过的提取物的组织形态显示出明显的β细胞幸存者。提取物改善了血脂异常,血浆HbA1C显着降低(p <0.05),而血浆胰岛素水平则明显升高。结论:该提取物可有效减轻高血糖症,引起HbAIC浓度显着下降并改善血脂水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号